发明授权
EP2113253B1 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines 有权
肿瘤相关肽的新型制剂结合于免疫接种I或II类的人白细胞抗原

Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
信息查询
0/0